NURZIGMA Trademark

Trademark Overview


On Sunday, November 13, 2022, a trademark application was filed for NURZIGMA with the United States Patent and Trademark Office. The USPTO has given the NURZIGMA trademark a serial number of 79366159. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by Prilenia Neurotherapeutics Ltd.. The NURZIGMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodevelopmental conditions and diseases; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical preparations for the prevention and treatment of Huntington disease and other neurological disorders
nurzigma

General Information


Serial Number79366159
Word MarkNURZIGMA
Filing DateSunday, November 13, 2022
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7265502
Registration DateTuesday, January 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodevelopmental conditions and diseases; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical preparations for the prevention and treatment of Huntington disease and other neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrilenia Neurotherapeutics Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIL

Party NamePrilenia Neurotherapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIL

Party NamePrilenia Neurotherapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events


Event DateEvent Description
Friday, March 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 30, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, April 4, 2023APPLICATION FILING RECEIPT MAILED
Saturday, August 26, 2023ASSIGNED TO EXAMINER
Saturday, August 26, 2023NON-FINAL ACTION WRITTEN
Sunday, August 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 18, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, September 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 4, 2023NOTICE OF PUBLICATION
Wednesday, October 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2023NOTIFICATION PROCESSED BY IB
Friday, April 12, 2024FINAL DISPOSITION PROCESSED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 15, 2024GENERIC MADRID TRANSACTION SENT TO IB
Monday, June 17, 2024NOTIFICATION PROCESSED BY IB
Wednesday, May 15, 2024GENERIC MADRID TRANSACTION CREATED
Friday, April 12, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 9, 2024IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Wednesday, May 15, 2024IRREGULARITY FROM IB EXAMINED BY MPU